A study of CTI-1601 for the treatment of Friedreich's Ataxia.

Adis International Ltd. Part of Springer Science+Business Media, Trials


Planning
Phase of Trial: Phase I
Latest Information Update: 14 Feb 2017


06 Feb 2017: According to a Chondrial Therapeutics media release, company is planning to file an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) and after acceptance of the IND, company will initiate this trial.


 A study of CTI-1601 for the treatment of Friedreich's Ataxia.